Memphis-based Vaxent, the vaccine-development company focused on Group A streptococcus (GAS), is likely to seek a commercialization partner or raise capital by 2014, said co-f.... Read More
Entrepreneurs of the world, Get Busy: You have nothing to lose but your income and your family. You've probably already lost your mind.
Okay, so Solidus partner Vic Gatto did.... Read More